As part of the ongoing Student/Postdoc-Run Speaker Series (SPRSS), and on behalf of the Neural Mechanisms of Psychedelic Drug Action Group, Dr. Deborah Mash from the University of Miami will give a talk titled "Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines.

Exploring the Future of VR and Digital Therapeutics

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

Breaking the Cycle of Addiction with Ibogaine

Ibogaine Receives Serious Media Attention

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other …

In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University …

The Kentucky Opioid Abatement Advisory Commission held its first public hearing Monday, July 17, to discuss funding development of an opioid-use disorder treatment using …

Deborah Mash is Professor of Neurology (Emeritus) and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She …

If you or a loved one struggle with addiction, this is an episode you’re going to want to listen to.  Many of …

Anne Phillipi of The New Health Club presents Dr. Deborah Mash – ibogaine can make you review your life Posted at 12:01h in Podcast by demerx …

DemeRx IB, Inc. CEO Deborah Mash joined Proactive New York to discuss the group’s joint venture with Atai Life Sciences (NASDAQ:ATAI), focused …

Source: https://www.healtheuropa.com/could-ibogaine-offer-a-revolutionary-long-term-solution-to-addiction/100635/ Derived from the iboga plant, ibogaine is a psychoactive compound that could have huge potential as a long-term solution to …

Yale Psychedelics Science Group presents Dr. Deborah Mash – Breaking the Cycle of Opioid Dependence with ibogaine Watch full webinar: 

Today’s episode features Deborah Mash, founder and CEO of DemeRx, a clinical stage company developing ibogaine therapies to treat substance use disorders. In this …

2020 has been a tough year for global markets and this is a trend that we have been closely following. During the …

CEO and co-founder of ATAI Life Sciences, Florian Brand explains why one psychedelic medicine might provide the key to fighting opioid addiction. …

“ibogaine made them ready for change,” says researcher Deborah Mash, PhD. Mash has been studying the effects of ibogaine since 1992. A psychedelic …

Ira Pastor, ideaXme exponential health ambassador and founder of Bioquark interviews Dr. Deborah Mash, Professor of Neurology and Molecular and Cellular Pharmacology at the Leonard M. Miller School …

The United States is struggling with a staggering opioid addiction epidemic—often starting with legitimate pain pill prescriptions, and ending with full-blown abuse. …

When Dr. Deborah Mash met the grandfather of ibogaine treatment, Howard Lotsof, and observed first-hand the effectiveness that ibogaine had for addiction …

Heroin addicts and alcoholics have said ibogaine helped them kick addiction, so why is it illegal in the United States? Read full …

News from Kron 4, San Fransisco. Dr. Mash is one of the few scientists in the world to study ibogaine, a mild …